Disease | N. SNPs d | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AFEXOME | AFGENOME | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Benign melanocytic nevus
|
20 | 0.653 | 0.320 | 7 | 140753336 | missense variant | AC/CT;TT | mnv | 0.010 | 1.000 | 1 | 2019 | 2019 | ||||||
Colon Carcinoma
|
275 | 0.653 | 0.320 | 7 | 140753336 | missense variant | AC/CT;TT | mnv | 0.010 | 1.000 | 1 | 2019 | 2019 | ||||||
Invasive Ductal Breast Carcinoma
|
12 | 0.653 | 0.320 | 7 | 140753336 | missense variant | AC/CT;TT | mnv | 0.010 | 1.000 | 1 | 2019 | 2019 | ||||||
Malignant Neoplasms
|
1441 | 0.653 | 0.320 | 7 | 140753336 | missense variant | AC/CT;TT | mnv | 0.010 | 1.000 | 1 | 2019 | 2019 | ||||||
Malignant tumor of colon
|
289 | 0.653 | 0.320 | 7 | 140753336 | missense variant | AC/CT;TT | mnv | 0.010 | 1.000 | 1 | 2019 | 2019 | ||||||
Melanoma recurrent
|
1 | 0.653 | 0.320 | 7 | 140753336 | missense variant | AC/CT;TT | mnv | 0.010 | 1.000 | 1 | 2019 | 2019 | ||||||
Colorectal Carcinoma
|
1186 | 0.653 | 0.320 | 7 | 140753336 | missense variant | AC/CT;TT | mnv | 0.020 | 1.000 | 2 | 2018 | 2019 | ||||||
Malignant neoplasm of colon and/or rectum
|
502 | 0.653 | 0.320 | 7 | 140753336 | missense variant | AC/CT;TT | mnv | 0.020 | 1.000 | 2 | 2018 | 2019 | ||||||
Melanocytic nevus
|
27 | 0.653 | 0.320 | 7 | 140753336 | missense variant | AC/CT;TT | mnv | 0.020 | 1.000 | 2 | 2018 | 2019 | ||||||
Non-Small Cell Lung Carcinoma
|
601 | 0.653 | 0.320 | 7 | 140753336 | missense variant | AC/CT;TT | mnv | 0.020 | 1.000 | 2 | 2018 | 2019 | ||||||
Lentigo maligna melanoma
|
6 | 0.653 | 0.320 | 7 | 140753336 | missense variant | AC/CT;TT | mnv | 0.010 | 1.000 | 1 | 2015 | 2015 | ||||||
Malignant melanoma, metastatic
|
5 | 0.653 | 0.320 | 7 | 140753336 | missense variant | AC/CT;TT | mnv | 0.010 | 1.000 | 1 | 2015 | 2015 | ||||||
Papillary thyroid carcinoma
|
193 | 0.653 | 0.320 | 7 | 140753336 | missense variant | AC/CT;TT | mnv | 0.010 | 1.000 | 1 | 2015 | 2015 | ||||||
Skin Neoplasms
|
7 | 0.653 | 0.320 | 7 | 140753336 | missense variant | AC/CT;TT | mnv | 0.010 | 1.000 | 1 | 2015 | 2015 | ||||||
Stage IV Cutaneous Melanoma AJCC v6 and v7
|
4 | 0.653 | 0.320 | 7 | 140753336 | missense variant | AC/CT;TT | mnv | 0.010 | 1.000 | 1 | 2015 | 2015 | ||||||
Stage IV Skin Melanoma
|
5 | 0.653 | 0.320 | 7 | 140753336 | missense variant | AC/CT;TT | mnv | 0.010 | 1.000 | 1 | 2015 | 2015 | ||||||
leukemia
|
138 | 0.653 | 0.320 | 7 | 140753336 | missense variant | AC/CT;TT | mnv | 0.020 | 1.000 | 2 | 2014 | 2016 | ||||||
Unresectable Melanoma
|
3 | 0.653 | 0.320 | 7 | 140753336 | missense variant | AC/CT;TT | mnv | 0.020 | 1.000 | 2 | 2014 | 2016 | ||||||
Advanced Melanoma
|
5 | 0.653 | 0.320 | 7 | 140753336 | missense variant | AC/CT;TT | mnv | 0.010 | 1.000 | 1 | 2014 | 2014 | ||||||
Childhood Leukemia
|
140 | 0.653 | 0.320 | 7 | 140753336 | missense variant | AC/CT;TT | mnv | 0.010 | 1.000 | 1 | 2014 | 2014 | ||||||
Neoplasms
|
1571 | 0.653 | 0.320 | 7 | 140753336 | missense variant | AC/CT;TT | mnv | 0.060 | 1.000 | 6 | 2013 | 2017 | ||||||
Metastatic melanoma
|
22 | 0.653 | 0.320 | 7 | 140753336 | missense variant | AC/CT;TT | mnv | 0.090 | 1.000 | 9 | 2012 | 2018 | ||||||
Metastatic malignant neoplasm to brain
|
28 | 0.653 | 0.320 | 7 | 140753336 | missense variant | AC/CT;TT | mnv | 0.010 | 1.000 | 1 | 2012 | 2012 | ||||||
Secondary malignant neoplasm of lung
|
20 | 0.653 | 0.320 | 7 | 140753336 | missense variant | AC/CT;TT | mnv | 0.010 | 1.000 | 1 | 2011 | 2011 | ||||||
Uveal melanoma
|
10 | 0.653 | 0.320 | 7 | 140753336 | missense variant | AC/CT;TT | mnv | 0.010 | 1.000 | 1 | 2008 | 2008 |